Literature DB >> 738349

Investigation into the species-specific deacylation of penta-acetyl-gitoxin.

K O Haustein, C Pachaly, R Megges, P Franke.   

Abstract

Penta-acetyl-gitoxin (PAG) shows species-specific deacylation to 16-acetyl-gitoxin (16 AG; I and III) or gitoxin (II and IV) by homogenates of liver and intestinal mucosa of man (I), rabbit (II), guinea-pig (III) and rat (IV), whereas it is degraded into tri- and tetra-acetates by homogenates of guinea-pig myocardium as well as by human blood and serum. The identity of the principal and chloroform-extractable metabolities in human urine after PAG administration with 16-AG has been demonstrated by mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 738349     DOI: 10.1007/bf00716384

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Body size and tissue respiration.

Authors:  H A KREBS
Journal:  Biochim Biophys Acta       Date:  1950-01

2.  [Metabolism of helveticoside and helveticosol derivatives].

Authors:  F Kaiser; W Schaumann
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

3.  Studies on cardioactive steroids. II. Structure-activity relationships in the isolated guinea-pig heart.

Authors:  K O Haustein; J Hauptmann
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

4.  Studies on cardioactive steroids. I. Structure-activity relationships on the isolated atrium.

Authors:  K O Haustein
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

5.  [Study of cardiac glycosides on healthy subjects].

Authors:  H Fiehring; I Assmann; H Schmidt; P Banse
Journal:  Cor Vasa       Date:  1973

6.  Studies on digitalis glycosides. Gitoxin acetates. 2. Deacetylation of pentaacetylgitoxin with liver and heart homogenates.

Authors:  J Morita; R Hirota; S Kimoto; T Mineshita
Journal:  Chem Pharm Bull (Tokyo)       Date:  1969-01       Impact factor: 1.645

7.  Cardiac effects of 16-acetyl-gitoxin, the active glycoside after penta-acetyl-gitoxin administration.

Authors:  K O Haustein; J Hauptmann; G Nowak
Journal:  Acta Biol Med Ger       Date:  1978

8.  Pharmacokinetic investigations with 3H-penta-acetyl-gitoxin in volunteers and patients with respect to the occurrence of drug latentiation.

Authors:  K O Haustein; C Pachaly; D Murawski
Journal:  Int J Clin Pharmacol Biopharm       Date:  1978-06

9.  [The enzymatic decomposition of D-digitoxose, D-cymarose and L-thevetose from cardiac glycosides by liver sections].

Authors:  F LAUTERBACH; K REPKE; D NITZ
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1960
  9 in total
  3 in total

1.  On the pharmacokinetics of pengitoxin and its cardioactive derivative 16-acetyl-gitoxin.

Authors:  K O Haustein; R G Alken; H J Lach; U Becker; N Rietbrock
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 2.  Extrahepatic metabolism of drugs in humans.

Authors:  D R Krishna; U Klotz
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

3.  On the pharmacokinetics of 16-acetyl-gitoxin and its bioavailability from pengitoxin-containing tablet formulations.

Authors:  K O Haustein
Journal:  J Pharmacokinet Biopharm       Date:  1986-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.